Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

Key drivers include technological advancements and evolving healthcare policies. The global market for short-acting insulin ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Regular insulin, which is often used in pregnancy for the treatment of diabetes, has some drawbacks: it starts its action from 30 to 60 min after subcutaneous injection and it peaks too late (2-3 ...

If you've recently received a diagnosis of type 2 diabetes, understanding your treatment options is an important first step.

Insulin icodec is an acylated insulin analogue that makes it bind strongly to albumin in the body and have reduced affinity for insulin receptors, effectively creating an inactive reservoir that ...

“The health ministry ensures patients get adequate treatment including increased use of an insulin analogue inhibitor,” he said. Dzulkefly had also attached a statement from the ministry in ...

If you have type 2 diabetes and take multiple insulin shots, you may want to ask your doctor about the insulin pump. Insulin pumps are small, computerized devices (about the size of a small cell ...

Insulin can be a critical part of managing diabetes, but patients may not know all the ins and outs of using the medication effectively. Luckily, the American Diabetes Association (ADA) has plenty ...

Akero Therapeutics has a solid cash runway and financial stability to support ongoing trials for its drug candidate. Read ...

DelveInsight's Short-Acting Insulin Market Insights report provides the current and forecast market analysis, individual ...